BSE & NSE
09 Feb - 13 Feb '24
₹1195 - ₹1258
Established in 2018, Entero Healthcare Solutions Limited operates as a healthcare product distributor in India, utilizing a technology-centric platform to extend its services to pharmacies, hospitals, and clinics nationwide.
Throughout the fiscal years 2021, 2022, and 2023, the company catered to increasing numbers of retail and hospital customers, with figures surpassing 39,500, 64,200, and 81,400 for retail customers and exceeding 1,600, 2,500, and 3,400 for hospital customers during the respective periods.
Entero Healthcare Solutions boasts partnerships with more than 1,900 healthcare product manufacturers, facilitating access to an extensive inventory of over 64,500 product stock-keeping units by March 31, 2023.Operating across 73 warehouses located in 37 cities within 19 states and union territories, the company's expansive reach serves over 81,400 pharmacies and 3,400 hospitals across 495 districts as of March 31, 2023, thereby ensuring robust connectivity with healthcare product manufacturers
|Application opens on
|9th February 2024
|Last date of application
|13th February 2024
|Date of Allotment
|14th February 2024
|Refund begins from
|15th February 2024
|Credit of shares to Demat
|15th February 2024
|16th February 2024
The primary objective of the company is to establish a structured and technology-oriented platform for distributing healthcare products, catering to the comprehensive healthcare ecosystem across India. By adopting a nationwide strategy, the company strategically acquires and integrates smaller distributors, thereby expanding its geographic coverage and enhancing its customer base.
The company intends to utilize the net proceeds from the fresh issue for the following purposes:
The company has a proven track record of expanding its operations through inorganic means, having successfully acquired 34 entities within the healthcare products distribution industry since the fiscal year 2018.
Check out the financial performance of Entero Healthcare Solutions for recent years:
|Rs 833.79 crore
|Rs 1,783.67 crore
|Rs -15.35 crore
|Rs 1,125.98 crore
|Rs 2,526.55 crore
|Rs -29.44 crore
|Rs 1,3908.73 crore
|Rs 3,305.72 crore
|Rs -11.10 crore
You can apply for the Entero Healthcare Solutions Ltd. IPO in these ways:
Link your personal bank A/C to a trusted UPI ID and map it with your TradeSmart account. Now, proceed further to book your IPO. On acceptance of the mandate, the bid amount will get blocked in your bank account Learn more.
What are the opening and closing dates for Entero Healthcare Solutions IPO?
Entero Healthcare Solutions IPO will open for subscription on February 9 and close on February 13.
What is the price band for Entero Healthcare Solutions IPO?
The price band for Entero Healthcare Solutions IPO is ₹1195 to ₹1258 per share.
Who is taking part in the OFS?
The OFS will include Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, who will offload shares.
What is the minimum and maximum lot size for the Entero Healthcare Solutions IPO?
Applications must have a minimum lot size of 11 share and multiples of thereof.
Who are Entero Healthcare Solutions IPO Lead Managers?
ICICI Securities, DAM Capital Advisors (IDFC Securities), Jefferies India, JM Financial and SBI Capital Markets are the joint Book Running Lead Managers (BRLMs) to the issue.
Who is the registrar of the issue?
Link Intime India is the registrar for Entero Healthcare Solutions IPO.
When will the Entero Healthcare Solutions IPO allotment take place?
The finalisation of the basis of allotment for Entero Healthcare Solutions IPO will be done on February 14 2024, and the allotted shares will be credited to investors’ demat accounts by February 15.
When and where will the Entero Healthcare Solutions shares be listed?
The equity shares of Entero Healthcare Solutions are proposed to be listed on February 16 ,2024, on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).